EUVIMEDEUVIMED entdecken
Crossref

Epidemiology, Clinical Features, and Outcomes of Proven Invasive Fungal Infections in Pediatric Patients

Selin Yıldız Sametoğlu iD, Seval Ozen, Gül Hatice Erkol Tuncer, Belgin Gülhan, Neriman Sarı, Saliha Kanık Yüksek, Derya Özyörük, Gülsüm İclal Bayhan, Neşe Yaralı, Fatih Üçkardeş, Turan Bayhan, Aslınur Özkaya Parlakay und 1 weitere

Mycopathologia · 2026-08 · 191 (4)

DOI: 10.1007/s11046-026-01094-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycopathologia, online erschienen am 24.07.2026. Verfasst von Selin Yıldız Sametoğlu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Universiteler Mahallesi, 06800, Cankaya, Ankara, Turkey. drselinyldz@outlo…. Hauptthemen laut MEDLINE: Invasive Fungal Infections. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections (IFIs) cause significant morbidity and mortality in immunocompromised pediatric patients; systematic data comparing mold- and yeast-related infections remain limited.

Objectives

To evaluate epidemiology, clinical features, antifungal treatment, and outcomes of proven infectious fungal infections (IFIs) in immunocompromised children, comparing mold and yeast infections. Patients/Methods This single-center retrospective study included 65 immunocompromised patients aged ≤ 18 years with proven IFIs diagnosed by the European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) criteria.

Results

Of 65 patients (75.4% male; median age 62 months), mold infections occurred in 21 (32.3%) and yeast infections in 44 (67.7%). Aspergillus spp. (n = 6) and Mucor spp. (n = 3) were common molds; Candida parapsilosis (n = 15) predominated among yeasts. ALL was more prevalent in the mold group (38.1% vs. 11.4%; p = 0.019), while other oncological malignancies predominated in the yeast group (50.0% vs. 19.0%; p = 0.017). Combination therapy (66.7% vs. 9.1%; p < 0.001), salvage therapy (52.4% vs. 27.3%; p = 0.048), and treatment duration (median 56 vs. 21 days; p < 0.001) were higher in the mold group. Mold infections showed higher rates of nodules, cavitation, and air-crescent sign on thoracic CT ( p < 0.05) and greater pulmonary progression (23.8% vs. 2.3%; p = 0.011). The overall pediatric intensive care unit (PICU) admission rate was 40.0%; mechanical ventilation was more frequent in the mold group (47.6% vs. 15.9%; p = 0.007) and was identified as the sole independent predictor of IFI-attributable mortality (OR 14.5; 95% CI 3.47–60.41; p < 0.001).Overall mortality was 36.9% with no between-group difference ( p = 0.892); IFI-attributable mortality was higher in the mold group (28.6% vs. 18.2%; p = 0.081).

Conclusions

Mold and yeast infections show distinct clinical, radiological, and therapeutic profiles in immunocompromised children, with mold infections showing greater treatment burden and higher IFI-attributable mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Fungal InfectionsHumansChildRetrospective StudiesChild, PreschoolMaleFemaleImmunocompromised HostAdolescentAntifungal AgentsInfantTreatment OutcomeFungiPrevalence

Stichwörter der Autor:innen

ChildrenImmunosuppressionInvasive fungal infectionMoldPediatric oncologyProvenYeast

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Universiteler Mahallesi, 06800, Cankaya, Ankara, Turkey. drselinyldz@outlook.com.
  • Department of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Universiteler Mahallesi, 06800, Cankaya, Ankara, Turkey.
  • Department of Pediatric Hematology/Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Department of Biostatistics and Medical Informatics, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey.
  • Department of Pediatric Hematology/Oncology, Ankara Yildirim Beyazit University Ankara Bilkent City Hospital, Ankara, Turkey.
  • Department of Pediatric Hematology/Oncology and Pediatric Bone Marrow Transplantation Unit, Ankara Bilkent City Hospital, Ankara, Turkey.

ORCID-Profile: Selin Yıldız Sametoğlu

Zitieren

APA

Yıldız Sametoğlu, S., Ozen, S., Erkol Tuncer, G. H., Gülhan, B., Sarı, N., Kanık Yüksek, S., Özyörük, D., Bayhan, G. İ., Yaralı, N., Üçkardeş, F., Bayhan, T., Özkaya Parlakay, A., & Özbek, N. Y. (2026). Epidemiology, Clinical Features, and Outcomes of Proven Invasive Fungal Infections in Pediatric Patients. Mycopathologia, 191(4). https://doi.org/10.1007/s11046-026-01094-1

Vancouver

Yıldız Sametoğlu S, Ozen S, Erkol Tuncer GH, Gülhan B, Sarı N, Kanık Yüksek S, et al. Epidemiology, Clinical Features, and Outcomes of Proven Invasive Fungal Infections in Pediatric Patients. Mycopathologia. 2026;191(4). doi:10.1007/s11046-026-01094-1

BibTeX
@article{YldzSametolu2026,
  author = {Yıldız Sametoğlu, Selin and Ozen, Seval and Erkol Tuncer, Gül Hatice and Gülhan, Belgin and Sarı, Neriman and Kanık Yüksek, Saliha and Özyörük, Derya and Bayhan, Gülsüm İclal and Yaralı, Neşe and Üçkardeş, Fatih and Bayhan, Turan and Özkaya Parlakay, Aslınur and Özbek, Namık Yaşar},
  title = {Epidemiology, Clinical Features, and Outcomes of Proven Invasive Fungal Infections in Pediatric Patients},
  journal = {Mycopathologia},
  year = {2026},
  volume = {191},
  number = {4},
  doi = {10.1007/s11046-026-01094-1}
}
Kostenlos starten →